Art. 3 Federal Act of 15 December 2000 on Medicinal Products and Medical Devices (TPA) - Due diligence
Legislator summary
AI generatedAny person handling therapeutic products must take all measures necessary according to the state of the art to ensure that human or animal health is not endangered. The state of the art in science and technology must be considered for complementary medicines without indications, including the principles of the corresponding therapy approach. {note: Inserted by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 ( AS 2017 2745, 2018 3575; BBl 2013 1).}
Art. 3 TPA · Due diligence
Any person handling therapeutic products must take all measures necessary according to the state of the art to ensure that human or animal health is not endangered.
The state of the art in science and technology must be considered for complementary medicines without indications, including the principles of the corresponding therapy approach.